Cargando…

P587: REAL-WORLD CHARACTERISTICS AND USE OF ANTIEMETIC THERAPIES AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH ORAL AZACITIDINE MAINTENANCE THERAPY

Detalles Bibliográficos
Autores principales:	Qiu, Ying, Chen, Jiafan, Sajeev, Gautam, Wang, Yao, Ye, Dongni, Ye, Mingchen, Chen, Jingyi, Quintana, Allison, Byrne, Clare, Huggar, David, Heydendael, Willem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429164/ http://dx.doi.org/10.1097/01.HS9.0000969252.00953.ba

Ejemplares similares

Cost-effectiveness analysis of oral azacitidine maintenance therapy in acute myeloid leukemia
por: Bewersdorf, Jan Philipp, et al.
Publicado: (2021)

Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine
por: Schlenk, R. F., et al.
Publicado: (2019)

Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia
por: Roboz, Gail J, et al.
Publicado: (2016)

Outcome of therapy-related myeloid neoplasms treated with azacitidine
por: Fianchi, Luana, et al.
Publicado: (2012)

P515: A REAL-WORLD EVALUATION OF TREATMENT PATTERNS AND OUTCOMES OF ACUTE MYELOID LEUKEMIA INDUCTION THERAPIES IN THE COMMUNITY SETTING
por: Maher, Keri, et al.
Publicado: (2023)

Analysis of Antiemetic Use After Initiation of Hormone Therapy
por: Rahbek, Martin Torp, et al.
Publicado: (2022)

Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Witlox, Willem, et al.
Publicado: (2023)

Induction of HCA587-Specific Antitumor Immunity with HCA587 Protein Formulated with CpG and ISCOM in Mice
por: Chen, Juanjuan, et al.
Publicado: (2012)

A Case of Leukemia Cutis with Acute Myeloid Leukemia on Azacitidine Therapy
por: Kara, Asude, et al.
Publicado: (2017)

A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment
por: Hardy, Janet, et al.
Publicado: (2018)

Azacitidine as Salvage Therapy for Acute Myeloid Leukemia in a Severely Ill Patient
por: Powers, Harry Ross, et al.
Publicado: (2014)

Successful Haploidentical Hematopoietic Stem Cell Transplantation with Azacitidine and Venetoclax Maintenance Therapy for Acute Myeloid Leukemia with NUP98-RARG Gene Fusion
por: Yuan, Jiaojiao, et al.
Publicado: (2023)

Antiemetics and Cancer Chemotherapy
por: Wilkinson, P.W.
Publicado: (1983)

Appropriate prescribing of antiemetics with oral oncolytic therapy: a single center experience
por: Suen, Connie T., et al.
Publicado: (2019)

Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin
por: Zhao, Yang, et al.
Publicado: (2021)

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial
por: Hunault-Berger, M, et al.
Publicado: (2017)

Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia
por: Dumas, Pierre-Yves, et al.
Publicado: (2017)

Gilteritinib Combined with Azacitidine as Salvage Therapy for B/Myeloid Mixed Phenotype Acute Leukemia
por: Horvat, Nathan P, et al.
Publicado: (2022)

Efficacy of Olanzapine Combined Therapy for Patients Receiving Highly Emetogenic Chemotherapy Resistant to Standard Antiemetic Therapy
por: Abe, Masakazu, et al.
Publicado: (2015)

587 Disparities in COVID-19 incidence and outcomes by insurance type
por: Arditi, Brittany, et al.
Publicado: (2021)

Hard-wired biases in trials: maintenance azacitidine in patients with acute myeloid leukemia and framework for future trials
por: Olivier, Timothée, et al.
Publicado: (2022)

587 Plasmapheresis in a Patient with “Refractory” Urticarial Vasculitis
por: Kartal, Ozgur, et al.
Publicado: (2012)

The effect of antiemetics in childhood gastroenteritis
por: Das, Jai K, et al.
Publicado: (2013)

Evaluation of Current Antiemetic Therapy Response in Patients Undergoing MEC or HEC Regimens in Portugal
por: Araújo, António, et al.
Publicado: (2023)

How to manage the initiation of apomorphine therapy without antiemetic pretreatment: A review of the literature
por: Isaacson, Stuart H., et al.
Publicado: (2022)

A Case of Recurrent Ovarian Cancer and Therapy-Related Acute Myeloid Leukemia Treated with Azacitidine
por: Ando, Kenju, et al.
Publicado: (2021)

PB1862: VENETOCLAX AND AZACITIDINE THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH SEVERE RENAL IMPAIRMENT
por: Naka, Ryosuke, et al.
Publicado: (2023)

The Novel Zinc Finger Protein 587B Gene, ZNF587B, Regulates Cell Proliferation and Metastasis in Ovarian Cancer Cells in vivo and in vitro
por: Liu, Yujie, et al.
Publicado: (2020)

Subcutaneous azacitidine maintenance in transplant-ineligible patients with acute myeloid leukemia: a single-center retrospective study
por: Johnson, Natacha, et al.
Publicado: (2023)

Mutations in histone modulators are associated with prolonged survival during azacitidine therapy
por: Tobiasson, Magnus, et al.
Publicado: (2016)

The effect of azacitidine therapy on the M protein of MDS patients with concomitant MGUS
por: Oka, Satoko, et al.
Publicado: (2018)

ENU-induced phenovariance in mice: inferences from 587 mutations
por: Arnold, Carrie N, et al.
Publicado: (2012)

Pharmacogenetic predictors of nausea and vomiting of pregnancy severity and response to antiemetic therapy: a pilot study
por: Lehmann, Amalia S, et al.
Publicado: (2013)

Formulation Design and Development of a Unani Transdermal Patch for Antiemetic Therapy and Its Pharmaceutical Evaluation
por: Saleem, Mohd Nauman, et al.
Publicado: (2016)

Multi-institutional survey of antiemetic therapy in lung cancer patients treated with carboplatin in Hokushin region
por: Ide, Takayuki, et al.
Publicado: (2023)

Complete Remission Obtained with Azacitidine in a Patient with Concomitant Therapy Related Myeloid Neoplasm and Pulmonary Mucormycosis
por: Capria, S., et al.
Publicado: (2013)

A retrospective assessment of real-world experience with venetoclax and azacitidine therapy in elderly acute myeloid leukemia
por: Hu, Rong-Hua, et al.
Publicado: (2022)

Predictors of the Overall Survival with Azacitidine Monotherapy in Untreated Acute Myeloid Leukemia Patients Ineligible for Intensive Therapy
por: Taenaka, Ryutaro, et al.
Publicado: (2022)

Oral Azacitidine and Cedazuridine Approximate Parenteral Azacitidine Efficacy in Murine Model
por: Ramsey, Haley E., et al.
Publicado: (2020)

Combination of Aprepitant, Azasetron, and Dexamethasone as Antiemetic Prophylaxis in Women with Gynecologic Cancers Receiving Paclitaxel/Carboplatin Therapy
por: Koshiyama, Masafumi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vlolo0ehkpnarcdbu7tks3l3i7